A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 3,399 shares of BIO stock, worth $1.11 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,399
Previous 4,296 20.88%
Holding current value
$1.11 Million
Previous $1.17 Million 3.07%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$263.97 - $344.64 $236,781 - $309,142
-897 Reduced 20.88%
3,399 $1.14 Million
Q2 2024

Jul 30, 2024

BUY
$268.26 - $339.48 $1.15 Million - $1.46 Million
4,296 New
4,296 $1.17 Million
Q4 2021

Feb 08, 2022

SELL
$708.84 - $794.68 $5.65 Million - $6.34 Million
-7,977 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$657.71 - $825.77 $122,991 - $154,418
187 Added 2.4%
7,977 $5.95 Million
Q2 2021

Aug 11, 2021

BUY
$576.64 - $649.04 $223,736 - $251,827
388 Added 5.24%
7,790 $5.02 Million
Q1 2021

May 13, 2021

BUY
$547.01 - $662.35 $51,965 - $62,923
95 Added 1.3%
7,402 $4.23 Million
Q4 2020

Feb 10, 2021

BUY
$510.68 - $643.45 $190,483 - $240,006
373 Added 5.38%
7,307 $4.26 Million
Q3 2020

Nov 12, 2020

BUY
$454.43 - $535.6 $844,330 - $995,144
1,858 Added 36.6%
6,934 $3.57 Million
Q2 2020

Aug 11, 2020

SELL
$334.87 - $493.06 $4.88 Million - $7.18 Million
-14,562 Reduced 74.15%
5,076 $2.29 Million
Q1 2020

May 12, 2020

BUY
$320.01 - $409.07 $971,550 - $1.24 Million
3,036 Added 18.29%
19,638 $6.88 Million
Q4 2019

Feb 12, 2020

SELL
$319.73 - $374.2 $2.85 Million - $3.34 Million
-8,925 Reduced 34.96%
16,602 $6.14 Million
Q3 2019

Nov 12, 2019

BUY
$304.55 - $345.24 $7.77 Million - $8.81 Million
25,527 New
25,527 $8.49 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.02B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.